Trial intelligence / Profile preview

Parasite Clearance in Vivax Malaria

TCTR20261031024Phase 4Not yet recruiting

Sponsor
Wellcome Trust
Start
Dec 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of artesunate, chloroquine in malaria, sponsored by Wellcome Trust. Planned start Dec 2026; status: not yet recruiting.

02

Drugs

artesunatechloroquine
03

Conditions

malaria

Beyond the preview

Go deeper on TCTR20261031024.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20261031024.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call